Literature DB >> 20560022

Stem cell therapy for chronic myocardial infarction.

Manuel Mazo1, Beatriz Pelacho, Felipe Prósper.   

Abstract

Although recent advances for the treatment of myocardial infarction have dramatically increased the rate of survival after the ischemic event, this has also led to a rise in the number of chronic patients, making the finding of a suitable therapy a compulsory subject for modern medicine. Over the last decade, stem cells have been a promise for the cure of several diseases not only due to their plasticity but also to their capacity to act in a paracrine manner and influence the affected tissue, prompting the launching of several clinical trials. In spite of the knowledge already acquired, stem cell application to chronically infarcted hearts has been much less approached than its acute counterpart. Through this review, we will focus in stem cell therapy in animal models of chronic myocardial infarction: cell types employed, functional results, mechanisms analyzed, and questions raised.

Entities:  

Mesh:

Year:  2010        PMID: 20560022     DOI: 10.1007/s12265-009-9159-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  89 in total

1.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

2.  Improvement of postnatal neovascularization by human adipose tissue-derived stem cells.

Authors:  A Miranville; C Heeschen; C Sengenès; C A Curat; R Busse; A Bouloumié
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

3.  Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.

Authors:  Paul W Armstrong; Christopher B Granger; Peter X Adams; Christian Hamm; David Holmes; William W O'Neill; Thomas G Todaro; Alec Vahanian; Frans Van de Werf
Journal:  JAMA       Date:  2007-01-03       Impact factor: 56.272

4.  Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction.

Authors:  M J van Amerongen; G Bou-Gharios; Er Popa; J van Ark; A H Petersen; G M van Dam; M J A van Luyn; M C Harmsen
Journal:  J Pathol       Date:  2008-02       Impact factor: 7.996

5.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

6.  Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.

Authors:  Juan J Gavira; Jesús Herreros; Ana Perez; María José Garcia-Velloso; Joaquín Barba; Francisco Martin-Herrero; Consuelo Cañizo; Ana Martin-Arnau; Josep M Martí-Climent; Milagros Hernández; Natalia López-Holgado; José María González-Santos; Cándido Martín-Luengo; Eduardo Alegria; Felipe Prósper
Journal:  J Thorac Cardiovasc Surg       Date:  2006-04       Impact factor: 5.209

7.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction.

Authors:  Yoshinori Miyahara; Noritoshi Nagaya; Masaharu Kataoka; Bobby Yanagawa; Koichi Tanaka; Hiroyuki Hao; Kozo Ishino; Hideyuki Ishida; Tatsuya Shimizu; Kenji Kangawa; Shunji Sano; Teruo Okano; Soichiro Kitamura; Hidezo Mori
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

8.  Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.

Authors:  D A Taylor; B Z Atkins; P Hungspreugs; T R Jones; M C Reedy; K A Hutcheson; D D Glower; W E Kraus
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

Review 9.  Guided stem cell cardiopoiesis: discovery and translation.

Authors:  Atta Behfar; Randolph S Faustino; D Kent Arrell; Petras P Dzeja; Carmen Perez-Terzic; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2008-09-26       Impact factor: 5.000

10.  Healing of myocardial infarcts in dogs. Effects of late reperfusion.

Authors:  V Richard; C E Murry; K A Reimer
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  7 in total

Review 1.  Adipose-derived stem cells for myocardial infarction.

Authors:  Manuel Mazo; Juan José Gavira; Beatriz Pelacho; Felipe Prosper
Journal:  J Cardiovasc Transl Res       Date:  2010-11-30       Impact factor: 4.132

Review 2.  Cardiovascular surgery for realization of regenerative medicine.

Authors:  Hidetoshi Masumoto; Ryuzo Sakata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-08-30

3.  Effects of sildenafil and/or muscle derived stem cells on myocardial infarction.

Authors:  Judy Sc Wang; Istvan Kovanecz; Dolores Vernet; Gaby Nolazco; George E Kopchok; Sheryl L Chow; Rodney A White; Nestor F Gonzalez-Cadavid
Journal:  J Transl Med       Date:  2012-08-07       Impact factor: 5.531

4.  Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap.

Authors:  Manuel Mazo; Miriam Araña; Beatriz Pelacho; Felipe Prosper
Journal:  Stem Cells Int       Date:  2012-01-22       Impact factor: 5.443

5.  Bone-marrow-derived mesenchymal stem cells for organ repair.

Authors:  Ming Li; Susumu Ikehara
Journal:  Stem Cells Int       Date:  2013-03-11       Impact factor: 5.443

6.  Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice.

Authors:  Silvia Mora-Lee; Ma Salomé Sirerol-Piquer; María Gutiérrez-Pérez; Ulises Gomez-Pinedo; Valerie D Roobrouck; Tania López; Mayte Casado-Nieto; Gloria Abizanda; Maria Teresa Rabena; Catherine Verfaille; Felipe Prósper; Jose Manuel García-Verdugo
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

7.  NF-E2-related factor 2 over-expression in mesenchymal stem cells to improve cellular cardiomyoplasty.

Authors:  Mohammad Mohammadzadeh-Vardin; Mehryar Habibi Roudkenar
Journal:  Electron Physician       Date:  2014-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.